Apollo (APOL) LBO Analysis Suggests 70-122% Upside - Piper Jaffray
Get Alerts APOL Hot Sheet
Rating Summary:
5 Buy, 12 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 16 | Down: 11 | New: 13
Join SI Premium – FREE
Piper Jaffray analyst, Peter Appert, believes that if Apollo (NASDAQ: APOL) can overcome the legal, regulatory and financial hurdles to complete a sale transaction, the valuation upside could be meaningful. His LBO analysis suggests a potential valuation of $13-$17 per share while a sum-of-parts valuation is $11 to $23. No change to Neutral rating or $9 PT since these hurdles still exist.
Considering an unlevered balance sheet, positive free cash flow and a depressed valuation, LBO values for APOL are intriguing assuming regulatory and legal hurdles can be overcome. A simple LBO model, assuming flat EBITDA beyond CY2018, 2x leverage and a 20% required IRR, yields an implied valuation of $13.
Not surprisingly, valuation is highly sensitive to changes in the key inputs and assuming 3x leverage and 10% EBITDA growth beginning in CY2019, the implied valuation rises to $17. Leverage higher than 2x or 3x is unlikely as it would raise red-flags with DoE and accreditors. However, the implied valuation still suggests meaningful valuation upside.
The market is implying minimal value to APOL's underlying operating assets considering the $6.50/share in net cash balances (excluding restricted cash). This likely undervalues Apollo's businesses, particularly its global portfolio of post-secondary institutions. If you assume a 1x-2x revenue multiple for Apollo Global and 0x-0.5x for University of Phoenix, the implied valuation for APOL is $11 to $23.
For an analyst ratings summary and ratings history on Apollo Education click here. For more ratings news on Apollo Education click here.
Shares of Apollo Education closed at $7.65 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Uniti Group (UNIT), Windstream Said To Near $15 Billion Combination - Bloomberg
- Sanofi (SNY) Said To Ask Banks To Pitch For Role On $20B OTC Spinoff - Bloomberg
- Evercore ISI Reiterates Outperform Rating on IBM (IBM), positive about potential HCP acqusition
Create E-mail Alert Related Categories
Analyst Comments, Hot Comments, Mergers and Acquisitions, RumorsRelated Entities
Piper Jaffray, Peter AppertSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!